- Home
- PTGX vs HHH Comparison
PTGX vs HHH Comparison
Compare PTGX & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- HHH
- Stock Information
- Founded
- PTGX 2006
- HHH 2010
- Country
- PTGX United States
- HHH United States
- Employees
- PTGX N/A
- HHH N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- PTGX Health Care
- HHH Real Estate
- Exchange
- PTGX Nasdaq
- HHH Nasdaq
- Market Cap
- PTGX 4.0B
- HHH 4.7B
- IPO Year
- PTGX 2016
- HHH N/A
- Fundamental
- Price
- PTGX $76.75
- HHH $78.91
- Analyst Decision
- PTGX Strong Buy
- HHH Buy
- Analyst Count
- PTGX 9
- HHH 2
- Target Price
- PTGX $78.11
- HHH $90.00
- AVG Volume (30 Days)
- PTGX 1.5M
- HHH 310.1K
- Earning Date
- PTGX 10-31-2025
- HHH 11-10-2025
- Dividend Yield
- PTGX N/A
- HHH N/A
- EPS Growth
- PTGX N/A
- HHH N/A
- EPS
- PTGX 0.80
- HHH 4.43
- Revenue
- PTGX $209,180,000.00
- HHH $1,770,945,000.00
- Revenue This Year
- PTGX N/A
- HHH N/A
- Revenue Next Year
- PTGX $142.86
- HHH $21.07
- P/E Ratio
- PTGX $95.33
- HHH $17.79
- Revenue Growth
- PTGX N/A
- HHH 80.45
- 52 Week Low
- PTGX $33.31
- HHH $61.41
- 52 Week High
- PTGX $93.25
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- PTGX 59.19
- HHH 43.51
- Support Level
- PTGX $73.08
- HHH $78.62
- Resistance Level
- PTGX $79.00
- HHH $83.05
- Average True Range (ATR)
- PTGX 2.93
- HHH 1.45
- MACD
- PTGX -0.37
- HHH -0.38
- Stochastic Oscillator
- PTGX 27.14
- HHH 14.64
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.